CTRI/2018/02/011928
Completed
未知
To evaluate the Safety & Efficacy of Facial Oxylife Spot Reduction Bleach System
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dabur India Limited
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Female Adult Subjects in general good health with age group of 18 to 60 years. Subjects who have not undergone any bleaching or facial procedure in past 6 weeks.
- •2\. Subjects willing to give a voluntary written informed consent for the participation in study and also photography release and agree to come for regular follow up.
- •3\. Subjects willing to abide by and comply with the study protocol.
- •4\. Subjects who are willing not to participate in any other clinical study during participation in the current study.
- •5\. Subjects who will qualify the sensitivity test will be enrolled in the study.
Exclusion Criteria
- •1\. A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients, or any ingredient of the test product.
- •2\. Present/current of intense sun exposure.
- •3\. Female volunteers with positive pregnancy test.
- •4\. Presence of any underlying clinically significant uncontrollable medical conditions
- •5\. Subject having active skin diseases (e.g. mild, moderate to severe acne vulgaris on the face or nodulocystic acne, psoriasis, active atopic dermatitis, lichen planus pigmentosus/Ashy dermatosis, pigmented contact dermatitis and active seborrhoeic dermatitis, tinea faciei or other cutaneous manifestations), which may interfere with the test readings.
- •6\. Subject on systematic medications (e.g. steroids, anti\-oxidant) which may compromise the study.
- •7\. Subjects who have excessive facial hair
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
EVALUATION OF EFFICACY AND SAFETY OF TOPICAL OXYMETAZOLINE 0.1% OPHTHALMIC SOLUTION IN TREATMENT OF ACQUIRED PTOSISHealth Condition 1: H024- Ptosis of eyelidCTRI/2022/08/044783DR RPCENTRE FOR OPHTHALMIC SCIENCES20
Recruiting
Phase 2
Evaluation the safety and effectiveness of Oxiplex Gel for reduction of pain and associated symptoms followingsingle level lumbar discectomyIRCT20141209020258N106Arak University of Medical Sciences60
Not yet recruiting
Not Applicable
Investigating the Efficacy and Safety of Oroxylum Indicum Extract on Overweight and Obese Subjects: A Randomized Controlled Clinical Trial (A Pilot Study)Overweight,obesityanti-hyperlipidemia effectTCTR20200520001Suranaree University of Technology100
Not yet recruiting
Not Applicable
Study to evaluate the effectiveness and safety of drug- oral tofacitinib in patients with Parthenium dermatitisCTRI/2023/10/058514AIIMS, New Delhi
Active, not recruiting
Phase 1
Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes - Safety and Efficacy of Moxidex Otic Solution in AOMTEUCTR2009-017319-13-BEAlcon Research Ltd.1,300